Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00482365 · ClinicalTrials.gov registry record
National Registry and Blood Bank of Patients With Liver Cancer
A clinical trial, sponsored by Vanderbilt-Ingram Cancer Center.
- Completed
- Registry status
- 151
- Enrollment target
NCT00482365: Completed study, sponsored by Vanderbilt-Ingram Cancer Center.
NCT00482365 is a clinical trial that has completed, run by Vanderbilt-Ingram Cancer Center. The registered enrollment target is 151 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00482365 has completed, sponsored by Vanderbilt-Ingram Cancer Center.
- COMPLETED
- Registry status
- 151 participants
- Enrollment target
Study Summary
RATIONALE: Gathering health information about patients with liver cancer over time may help doctors learn more about the disease and may help the study of cancer in the future. PURPOSE: This clinical trial is developing a national registry and blood bank of patients with liver cancer.
Primary Outcome
A descriptive analysis will be done to describe the number of patients with HCC, their underlying etiology, correlation between etiology and demographic features and the outcome of various forms of therapy. Survival analysis will be done, comparing various forms of therapy while adjusting for stage of disease.
Interventions
- OTHER biologic sample preservation procedure
- OTHER medical chart review
- OTHER Patient interview
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 151 participants |
| Start Date | 2002-04 |
| Est. Completion | 2009-08 |
What the finished NCT00482365 record still lists
NCT00482365 is an observational study that tracks outcomes without assigning an intervention. The registered 151 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 3 interventions - of which biologic sample preservation procedure is the first listed.
NCT00482365 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00482365 about?
NCT00482365 is a clinical study titled "National Registry and Blood Bank of Patients With Liver Cancer". RATIONALE: Gathering health information about patients with liver cancer over time may help doctors learn more about the disease and may help the study of cancer in the future. PURPOSE: This clinical trial is developing a national registry and blood bank of patients with liver cancer.
What is the current status of trial NCT00482365?
This trial is currently completed. The enrollment target is 151 participants. The study started on 2002-04. Estimated completion is 2009-08.
What interventions are being tested in trial NCT00482365?
The interventions under investigation include: biologic sample preservation procedure (OTHER), medical chart review (OTHER), Patient interview (OTHER).
Who is sponsoring clinical trial NCT00482365?
This trial is sponsored by Vanderbilt-Ingram Cancer Center, which has 189 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01409161 · 151 participants · Phase 2
Tretinoin and Arsenic Trioxide With or Without Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
- NCT04245397 · 151 participants · Phase 1
Study of SX-682 Alone and in Combination With Oral or Intravenous Decitabine in Subjects With Myelodysplastic Syndrome
- NCT05761223 · 151 participants · Phase 1
A Phase I/II, Open-label Study to Investigate the Safety, Tolerability, PK, and Preliminary Efficacy of FB849
- NCT07195656 · 151 participants · NA
Evaluation of a Non-Implanted Electrical Stimulation Device for Overactive Bladder (OAB)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia